Onderneming Biocorrx Inc Other OTC
Aandelen
US09073C1062
Gezondheidszorgvoorzieningen & -diensten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Distribution Rights
37,3
%
| 0 | 17,4 % | 0 | 37,3 % | -10,83% |
Project Support
29,0
%
| 0 | 70,4 % | 0 | 29,0 % | -82,85% |
Sales/Access
23,4
%
| 0 | 6,7 % | 0 | 23,4 % | +45,21% |
Membership/Program
10,4
%
| 0 | 5,4 % | 0 | 10,4 % | -20,46% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -58,31% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lourdes Felix
CEO | Chief Executive Officer | 56 | 01-10-12 |
Kent Emry
CHM | Chairman | 55 | 13-09-13 |
Louis Lucido
PSD | President | 75 | 01-03-19 |
Thomas Welch
PRN | Corporate Officer/Principal | - | 01-01-14 |
Dave de Csepel
PRN | Corporate Officer/Principal | - | - |
Balbir S. Brar
PRN | Corporate Officer/Principal | 87 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Louis Lucido
PSD | President | 75 | 01-03-19 |
Joe Galligan
BRD | Director/Board Member | 64 | 01-04-19 |
Luisa Ingargiola
BRD | Director/Board Member | 56 | 01-03-19 |
Lourdes Felix
CEO | Chief Executive Officer | 56 | 01-10-12 |
Kent Emry
CHM | Chairman | 55 | 13-09-13 |
Director/Board Member | 63 | 08/02 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 160 000 | 0 | 0 | 38,77 % |
Aandeel B | 1 | 8 815 454 | 3 417 320 ( 38,77 %) | 0 | |
Aandeel C | 0 | 80 000 | 0 | 0 |
Bedrijfsgegevens
BioCorRx, Inc.
2390 East Orangewood Avenue Suite 500
92806, Anaheim
+714 462 4880
http://www.biocorrx.comSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,18% | 83,07 mld. | |
-28,48% | 70,89 mld. | |
+4,79% | 28,32 mld. | |
-7,44% | 17,73 mld. | |
+1,85% | 17,43 mld. | |
+2,10% | 15,64 mld. | |
+7,02% | 13,46 mld. | |
+64,96% | 12,69 mld. | |
+7,40% | 12,82 mld. |